TOTAL VOLUME:

$142.3b

24H VOL:

$107,419,736

24H TRANSACTIONS:

2,643,541,936

OPEN INTEREST:

$1,594,026,835

471,138

Markets across

35,775

events

MATCHED EVENTS:

2,926

PLATFORM COVERAGE:

5

Polymarket:

38%

VS.

Kalshi:

62%

BETA
Dashboards
Tour
All
Science and Technology
Will a pneumonic plague case be reported in the U.S. this year?
kalshi

Will a pneumonic plague case be reported in the U.S. this year?

Oct 5, 2026, 2:00 AM EST - Jan 1, 2027, 12:00 AM EST
Total volume:
$82,336
Volume 24h:
$12,925
48%
Liquidity:
N/AN/A
Open interest:
$44,112
13%

Before January 1, 2027

 - Kalshi

Before January 1, 2027 - Kalshi

1W

News

Positive

Negative

Neutral

Hover marker for details

Vol.

·

Resolves Jan 1, 2027

Will a confirmed human case of pneumonic plague be reported in the United States before January 1, 2027?

13%chance
Amount

$

Trade on
kalshi

Trade on Kalshi

Join Kalshi and score $25 for your first trade.At 14¢ buys you 714 shares | Odds: 13% Total Payout: $714 | Net Profit: $614 Multiplier: 7.14x | ROI: 614% APY not meaningful 78 days to resolution
You will be redirected to the platform to complete this trade.
Outcome
Trade
Chance %
Price
Spread
Liquidity
Volume
24h
7d
Open Interest
Ends in
Result
kalshi

Before January 1, 2027

Trade
13%
1%
Yes 14¢No 87¢
1¢
N/A
$19,946
1%
82%
$11,346
2mo 2w 4d
active
kalshi

Before November 1, 2026

7%
3%
Yes 7¢No 94¢
1¢
N/A
$32,869
26%
217%
$17,814
2mo 2w 4d
active
kalshi

Before December 1, 2026

4%
5%
Yes 5¢No 96¢
1¢
N/A
$29,521
20%
112%
$14,951
2mo 2w 4d
active
Total markets: 3

Description

This event tracks whether health authorities in the United States will confirm an instance of pneumonic plague in a human patient within a defined timeframe. The focus is strictly on officially documented cases of the specific pneumonic form of the disease, whether contracted domestically or identified upon entry. Only confirmations after the market's start and before the stated deadline count, regardless of when symptoms first appeared.

Kalshi

The event resolves to Yes if any confirmed human case of pneumonic plague is officially reported within the United States by a designated Source Agency at any point after the market issuance and before the earliest of three possible deadlines: November 1, 2026, December 1, 2026, or January 1, 2027. All three market conditions share identical secondary criteria: the case must involve human pneumonic plague specifically—excluding bubonic, septicemic, unspecified plague, or animal infections. The diagnosis must be confirmed within U.S. territory; diagnoses of U.S. citizens abroad do not qualify. Cases identified through importation into the United States are valid, independent of any broader outbreak contexts. Crucially, only the first official confirmation occurring within the relevant time window determines the outcome; symptom onset or infection prior to the deadline is irrelevant if formal confirmation happens afterward. The market evaluates all qualifying confirmations collectively, with the earliest applicable deadline governing resolution should multiple cases occur across the three periods.

Frequently asked questions

On Kalshi, the dashboard for the pneumonic plague market tracks the current odds of a confirmed case being reported in the U.S. before Jan 1, 2027. You’ll find a price history showing how those odds have changed over time, reflecting trader sentiment. The dashboard also displays the 24-hour trading volume, currently at $12,760, and the total volume traded to date, which is $82,336. This provides a clear picture of market activity and how participants are assessing the likelihood of this event.

Currently, assessing whether a pneumonic plague case will be reported in the U.S. differs between expert opinion and this market. While public health analysts often provide risk assessments based on epidemiological models and historical data, this market represents a collective forecast from a diverse range of participants. It’s important to note that analyst forecasts are often qualitative, while this market provides a quantitative probability expressed through trading activity. Discrepancies can arise due to differing interpretations of available information and varying risk tolerances among traders.

On Kalshi, this market is priced using a continuous double auction, meaning traders buy and sell contracts representing a 'yes' or 'no' outcome to the question of whether a pneumonic plague case will be reported in the U.S. before Jan 1, 2027. The price of these contracts fluctuates based on supply and demand, reflecting the collective belief of traders. On Kalshi, prices reflect that venue's order book, liquidity, and how traders price the outcome right now. The current price indicates the probability that traders assign to the event occurring, with higher prices suggesting a greater perceived likelihood.

This market resolves around Jan 1, 2027, with the outcome confirmed once the event is verifiable from credible public reporting. Specifically, the resolution will depend on whether a confirmed human case of pneumonic plague is reported to and verified by recognized public health authorities within the United States before the resolution date. The outcome will be determined based on official reports and data released by these authorities, providing a transparent and objective assessment of whether the event occurred.

Several signals could significantly impact this market. Any confirmed reports of plague cases, even if not pneumonic, in regions with close ties to the U.S. could raise concerns and increase trading volume. Public health announcements regarding increased surveillance or vaccination efforts related to plague could also influence the market. Additionally, news about outbreaks of similar zoonotic diseases or changes in environmental factors that favor plague transmission could shift trader sentiment and move the odds. Unexpected travel patterns or reports of unusual animal die-offs could also be catalysts.